A detailed history of Founders Financial Securities LLC transactions in Haleon PLC stock. As of the latest transaction made, Founders Financial Securities LLC holds 119,788 shares of HLN stock, worth $1.28 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
119,788
Previous 102,760 16.57%
Holding current value
$1.28 Million
Previous $1.09 Million 5.34%
% of portfolio
0.11%
Previous 0.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$9.23 - $10.71 $157,168 - $182,369
17,028 Added 16.57%
119,788 $1.15 Million
Q3 2024

Nov 12, 2024

BUY
$8.32 - $10.7 $218,391 - $280,864
26,249 Added 34.31%
102,760 $1.09 Million
Q2 2024

Aug 02, 2024

BUY
$8.01 - $8.64 $92,531 - $99,809
11,552 Added 17.78%
76,511 $631,000
Q1 2024

Apr 17, 2024

BUY
$8.02 - $8.67 $520,971 - $563,194
64,959 New
64,959 $551,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $49.3B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Founders Financial Securities LLC Portfolio

Follow Founders Financial Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Founders Financial Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Founders Financial Securities LLC with notifications on news.